5 | ixekizumabIBA
01/2023
-
12/2017 |
4 | Monoclonal AntibodiesIBA
01/2023
-
10/2018 |
4 | Interleukin-17 (Interleukin 17)IBA
01/2023
-
10/2018 |
4 | Glutamic Acid (Glutamate)FDA Link
01/2018
-
01/2011 |
2 | AntibodiesIBA
10/2018
-
12/2017 |
2 | LigandsIBA
01/2018
-
01/2016 |
2 | LY2940094IBA
01/2016
-
01/2016 |
2 | NociceptinIBA
01/2016
-
01/2016 |
2 | ProdrugsIBA
02/2012
-
06/2011 |
2 | pomaglumetad methionilIBA
02/2012
-
06/2011 |
2 | 4- aminho- 2- thiabicyclo(3.1.0)hexane- 4,6- dicarboxylic acidIBA
02/2012
-
06/2011 |
1 | N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2018 |
1 | Cholinergic Agents (Cholinergics)IBA
01/2018 |
1 | Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
12/2017 |
1 | InterleukinsIBA
12/2017 |
1 | VaccinesIBA
12/2017 |
1 | Insulin Aspart (NovoLog)FDA Link
01/2017 |
1 | Insulin (Novolin)FDA Link
01/2017 |
1 | Nociceptin ReceptorIBA
01/2016 |
1 | 3- (9- fluoro- 2- (piperidin- 1- ylcarbonyl)- 1,2,3,4- tetrahydro(1,4)diazepino(6,7,1- hi)indol- 7- yl)- 4- imidazo(1,2- a)pyridin- 3- yl- 1H- pyrrole- 2,5- dioneIBA
01/2016 |
1 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2016 |
1 | TransferasesIBA
01/2016 |
1 | Glycogen Synthase (Synthase I)IBA
01/2016 |
1 | Peptide Receptors (Peptide Receptor)IBA
01/2016 |
1 | Antidepressive Agents (Antidepressants)IBA
01/2016 |
1 | Methionine (L-Methionine)FDA Link
02/2012 |
1 | Olanzapine (Zyprexa)FDA Link
06/2011 |
1 | Leukocyte Elastase (Neutrophil Elastase)IBA
08/2004 |
1 | sivelestatIBA
08/2004 |